Integral Health Asset Management’s Blueprint Medicines BPMC Stock Holding History

Integral Health Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-145,000	Closed	-$12.8M	–	80
2025 Q1	$12.8M	Sell	145,000 -130,000	-47%	-$12.7M	1.37%	22
2024 Q4	$24M	Sell	275,000 -15,000	-5%	-$1.37M	2.04%	12
2024 Q3	$26.8M	Sell	290,000 -50,000	-15%	-$4.97M	3.02%	8
2024 Q2	$36.6M	Buy	340,000 +130,000	+62%	+$13M	3.48%	6
2024 Q1	$19.9M	Buy	210,000 +70,000	+50%	+$6M	1.85%	20
2023 Q4	$12.9M	Buy	140,000 +90,000	+180%	+$5.83M	1.76%	20
2023 Q3	$2.51M	Buy	+50,000	New	+$2.67M	0.35%	62
2022 Q4	–	Sell	-93,000	Closed	-$6.13M	–	69
2022 Q3	$6.13M	Sell	93,000 -37,000	-28%	-$2.38M	1.19%	37
2022 Q2	$6.57M	Sell	130,000 -23,000	-15%	-$1.35M	1.35%	28
2022 Q1	$9.77M	Buy	153,000 +78,000	+104%	+$5.6M	2.54%	14
2021 Q4	$8.03M	Sell	75,000 -23,000	-23%	-$2.41M	2.22%	15
2021 Q3	$10.1M	Sell	98,000 -2,000	-2%	-$186K	2.9%	8
2021 Q2	$8.8M	Sell	100,000 -17,500	-15%	-$1.6M	2.42%	12
2021 Q1	$11.4M	Buy	117,500 +32,500	+38%	+$3.24M	3.26%	6
2020 Q4	$9.53M	Sell	85,000 -20,000	-19%	-$2.11M	2.84%	11
2020 Q3	$9.73M	Sell	105,000 -5,000	-5%	-$385K	2.98%	8
2020 Q2	$8.58M	Buy	110,000 +50,000	+83%	+$3.38M	2.57%	11
2020 Q1	$3.51M	Buy	60,000 +40,000	+200%	+$2.57M	1.55%	28
2019 Q4	$1.6M	Buy	+20,000	New	+$1.5M	0.62%	44

Other funds holding BPMC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Integral Health Asset Management's BPMC Position: Q2 2025 in Review

Integral Health Asset Management sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 145,000 shares — an estimated $12.8M sold.

Integral Health Asset Management first reported a position in BPMC in Q4 2019 and held it in 19 quarters. The position peaked at $36.6M in Q2 2024. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

Integral Health Asset Management reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
Integral Health Asset Management sold 145,000 Blueprint Medicines shares in Q2 2025, an estimated $12.8M.
Integral Health Asset Management first reported a position in Blueprint Medicines in Q4 2019 and held it in 19 quarters.
Integral Health Asset Management's Blueprint Medicines position peaked at $36.6M in Q2 2024.
354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Integral Health Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.